Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of High Efficient Killing Cell Therapy for Advanced Non Small Cell Lung Cancer

NCT03193567 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03193567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of High Efficient Killing Cell Therapy for Advanced Non Small Cell Lung Cancer
Lead sponsor
Ruijin Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
September 14, 2017
Completion date
May 1, 2025
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer